收费全文 | 15158篇 |
免费 | 1088篇 |
国内免费 | 64篇 |
耳鼻咽喉 | 138篇 |
儿科学 | 424篇 |
妇产科学 | 388篇 |
基础医学 | 2161篇 |
口腔科学 | 432篇 |
临床医学 | 1564篇 |
内科学 | 3036篇 |
皮肤病学 | 233篇 |
神经病学 | 1483篇 |
特种医学 | 1045篇 |
外科学 | 2569篇 |
综合类 | 87篇 |
一般理论 | 2篇 |
预防医学 | 795篇 |
眼科学 | 267篇 |
药学 | 751篇 |
中国医学 | 27篇 |
肿瘤学 | 908篇 |
2023年 | 113篇 |
2022年 | 214篇 |
2021年 | 456篇 |
2020年 | 271篇 |
2019年 | 416篇 |
2018年 | 453篇 |
2017年 | 327篇 |
2016年 | 369篇 |
2015年 | 429篇 |
2014年 | 580篇 |
2013年 | 659篇 |
2012年 | 960篇 |
2011年 | 966篇 |
2010年 | 562篇 |
2009年 | 536篇 |
2008年 | 738篇 |
2007年 | 724篇 |
2006年 | 681篇 |
2005年 | 648篇 |
2004年 | 577篇 |
2003年 | 566篇 |
2002年 | 448篇 |
2001年 | 343篇 |
2000年 | 340篇 |
1999年 | 322篇 |
1998年 | 121篇 |
1997年 | 124篇 |
1996年 | 99篇 |
1995年 | 62篇 |
1994年 | 71篇 |
1993年 | 80篇 |
1992年 | 210篇 |
1991年 | 200篇 |
1990年 | 176篇 |
1989年 | 177篇 |
1988年 | 159篇 |
1987年 | 172篇 |
1986年 | 148篇 |
1985年 | 173篇 |
1984年 | 122篇 |
1983年 | 101篇 |
1982年 | 63篇 |
1981年 | 70篇 |
1979年 | 91篇 |
1978年 | 93篇 |
1975年 | 66篇 |
1974年 | 71篇 |
1973年 | 68篇 |
1972年 | 76篇 |
1971年 | 68篇 |
Areas covered: We discuss the current understanding of the HH pathway as it relates to normal hematopoiesis, the pathology of acute myeloid leukemia (AML), the rationale for and data from combination therapies including HH pathway inhibitors, and ultimately the prospects that might offer promise in targeting this pathway in AML.
Expert opinion: Efforts to target the HH pathway have been focused on impeding this disposition and restoring chemosensitivity to conventional myeloid neoplasm therapies. The year 2018 saw the first approval of a HH pathway inhibitor (glasdegib) for AML, though for an older population and in combination with an uncommonly-used therapy. Several other clinical trials with agents targeting modulators of HH signaling in AML and MDS are underway. Further study and understanding of the interplay between the numerous aspects of HH signaling and how it relates to the augmented survival of AML will provide a more reliable substrate for therapeutic strategies in patients with this poor-risk disease. 相似文献
Objective
To assay peripheral inter-ictal cytokine serum levels and possible relations with non-invasive vagus nerve stimulation (nVNS) responsiveness in migraineurs.Methods
This double-blinded, sham-controlled study enrolled 48 subjects and measured headache severity, frequency [headache days/month, number of total and mild/moderate/severe classified attacks/month], functional state [sleep, mood, body weight, migraine-associated disability] and serum levels of inflammatory markers [inter-ictal] using enzyme-linked immunoassays at baseline and after 2 months of adjunctive nVNS compared to sham stimulation and suitably matched controls.Results
No significant differences were observed at baseline and after 2 months for headache severity, total attacks/month, headache days/month and functional outcome [sleep, mood, disability] between verum and sham nVNS. However, the number of severe attacks/month significantly decreased in the verum nVNS group and circulating pro-inflammatory IL-1β was elevated significantly in the sham group compared to nVNS. Levels of anti-inflammatory IL-10 were significantly higher at baseline in both groups compared to healthy controls, but not at 2 months follow-up [p?<?0.05]. Concentrations of high-mobility group box-1 (HMGB-1), IL-6, tumor-necrosis factor-α (TNF-α), leptin, adiponectin, ghrelin remained unchanged [p?>?0.05]. No severe device-/stimulation-related adverse events occurred.Conclusion
2 months of adjunctive cervical nVNS significantly declined the number of severe attacks/month. Pro-inflammatory IL-1β plasma levels [inter-ictal] were higher in sham-treated migraine patients compared to verum nVNS. However, pro- [IL-6, HMGB-1, TNF-α, leptin] and anti-inflammatory [IL-10, adiponectin, ghrelin] mediators did not differ statistically. Profiling of neuroinflammatory circuits in migraine to predict nVNS responsiveness remains an experimental approach, which may be biased by pre-analytic variables warranting large-scale biobank-based systematic investigations [omics]. 相似文献Methods This investigation, on infants aged from 1 to 6 months, was approved by the institutional ethic committee. Thirty-six otherwise healthy infants due to elective surgery were included in our study The patients were randomly assigned to one of two treatment groups. Group S ( n = 24) was anaesthetised with sevoflurane, Group H was anaesthetised with halothane. ECG recordings were taken before the anaesthesia onset, 15 min after the first contact with the volatile anaesthetic and 60 min after the ending of the volatile gas exposition. QTc interval was calculated using the Bazett's formula ( 5 ).
Results QTc interval was significantly ( P < 0.0002) (Table 1) lengthened 15 min after anaesthesia induction with sevoflurane as well as 60 min ( P < 0.01) after the ending of the gas exposition without any difference in age and gender. The QTc interval in patients anaesthetised with halothane did not show any significant change.
Table 1 相似文献